✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹11 Cr.
P/E
0.00

Key Ratios

Market cap
Market cap
11.00 Cr
PE
PE
-
Prom Holding
Prom Holding
16.16 %
ROE (%)
ROE (%)
-20.54
ROCE (%)
ROCE (%)
-20.41
Div Yield (%)
Div Yield (%)
-
Sales
Sales
0.08 Cr
OPM (%)
OPM (%)
39.02 %
Debt to Equity
Debt to Equity
0.12
About
Transpact Enterprises Limited has been engaged in the business of producing significantly need… Read more
Low
131
52W Range
High
350
  • Transpact Enterprise
  • Laser Eyecare
  • Shree Pacetronix

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

4 No

Negative for this company

5 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison
FAQs on Transpact Enterprises Ltd. Business

Transpact Enterprises Limited produces essential medico-products to improve human society by helping people overcome barriers and create a positive impact on their lives.

Transpact Enterprise major competitors are Laser Eyecare, Shree Pacetronix, GKB Ophthalmics, KMS Medisurgi, Amkay Products, Centenial Surgical, Hemant Surgical Inds.
Market Cap of Transpact Enterprise is ₹11 Crs.
While the median market cap of its peers are ₹42 Crs.

Transpact Enterprise seems to be less financially stable compared to its competitors.
Altman Z score of Transpact Enterprise is 0 and is ranked 7 out of its 8 competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material